We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+4.88%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$7.27B
AUM Growth
-$3.18B
Cap. Flow
-$3.49B
Cap. Flow %
-48.04%
Top 10 Hldgs %
56.37%
Holding
88
New
13
Increased
18
Reduced
20
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 18.02%
2 Communication Services 13.28%
3 Healthcare 12.3%
4 Industrials 8.08%
5 Consumer Discretionary 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRMR icon
51
Larimar Therapeutics
LRMR
$434M
$5.02M 0.07%
69,900
PLCM
52
DELISTED
POLYCOM INC
PLCM
$4.72M 0.07%
+420,000
New +$4.9M
MITL
53
DELISTED
Mitel Networks Corporation
MITL
$4.32M 0.06%
+687,100
New +$4.69M
PCO
54
DELISTED
Pendrell Corporation - Class A
PCO
$4.31M 0.06%
8,539
+450
+6% +$248K
GWPH
55
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.66M 0.05%
40,000
-20,000
-33% -$1.68M
RAD
56
DELISTED
Rite Aid Corporation
RAD
$3.54M 0.05%
+23,601
New +$3.72M
EJ
57
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
$2.45M 0.03%
379,202
CMRX
58
DELISTED
Chimerix, Inc.
CMRX
$2.33M 0.03%
593,138
-101,862
-15% -$503K
GCVRZ
59
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$671K 0.01%
2,794,805
+2,546,110
+1,024% +$438K
AAL icon
60
American Airlines Group
AAL
$9.15B
-758,300
Closed -$31.1M
BHC icon
61
Bausch Health
BHC
$2.41B
-269,700
Closed -$7.09M
CF icon
62
CF Industries
CF
$19.6B
-1,650,000
Closed -$51.7M
KLAC icon
63
KLA
KLAC
$240B
-8,575,000
Closed -$62.4M
ODP
64
DELISTED
ODP
ODP
-85,500
Closed -$6.07M
RYAAY icon
65
Ryanair
RYAAY
$28.9B
-216,065
Closed -$7.42M
THS
66
DELISTED
Treehouse Foods
THS
-1,228,053
Closed -$107M
VTVT icon
67
vTv Therapeutics
VTVT
$132M
-1,709
Closed -$353K
XLK icon
68
PUT
State Street Technology Select Sector SPDR ETF
XLK
$120B
-3,600,000
Closed -$79.8M
TUMI
69
DELISTED
TUMI HLDGS INC COM
TUMI
-285,000
Closed -$7.64M
TE
70
DELISTED
TECO ENERGY INC
TE
-1,460,000
Closed -$40.2M
CVC
71
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
-1,060,000
Closed -$35M
BXLT
72
DELISTED
BAXALTA INC COM STK (DE)
BXLT
-8,755,000
Closed -$354M
SNDK
73
DELISTED
SANDISK CORP
SNDK
-6,050,000
Closed -$460M
SNDK
74
PUT
DELISTED
SANDISK CORP
SNDK
-700,000
Closed -$53.3M
ADT
75
DELISTED
ADT Corp
ADT
-1,455,000
Closed -$60M

Similar funds

Thomas Steyer's Q2 2016 Portfolio in Review

As of Q2 2016, Thomas Steyer held 88 positions worth $7.27B, down 30% from $10.5B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Thomas Steyer withdrew a net $3.49B in Q2 2016, closing 24 positions and reducing 20 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $776M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Thomas Steyer opened a new position in St Jude Medical worth $359M.

  • Thomas Steyer's largest Q2 2016 buy was St Jude Medical: 4,600,000 shares worth $359M.
  • Thomas Steyer added most to Signet Jewelers in Q2 2016, an estimated $91.4M increase.
  • Thomas Steyer's biggest Q2 2016 reduction was Humana, cutting an estimated $172M.
  • Thomas Steyer fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $776M.
  • Thomas Steyer's ten largest holdings make up 56% of its $7.27B portfolio in Q2 2016.
  • Thomas Steyer opened 13 new positions and closed 24 in Q2 2016.
  • Thomas Steyer's portfolio value fell 30% quarter-over-quarter to $7.27B.

Based on Farallon Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.